BACKGROUND: Crohn's disease (CD) has been associated with CARD15/NOD2 mutations in Caucasians. The R702W, G908R, and 1007fs mutations represent 82% of the mutated chromosomes. The relative risk of developing CD in homozygous or compound heterozygous people has been estimated as between 10 and 40 times that of the general population. This high risk may support the opinion that CARD15/NOD2 variants are strong CD risk factors at the individual and population levels. SUBJECTS AND METHODS: The allele and genotype frequencies were calculated for the R702W, G908R, and 1007fs mutations in 3,575 Caucasian healthy controls recruited by 15 groups distributed on three continents. Geographic homogeneity was tested and the observed proportion of double mutants was compared with the expected value using chi2 tests. RESULTS: The allele frequencies of the R702W, G908R, and 1007fs mutations were 4.3% (3.6-4.9), 1.2% (0.8-1.6), and 2.3% (1.8-2.8), respectively, with large geographic fluctuations of the G908R, 1007fs, and wild-type alleles (P<0.0001). At the population level, no simple relationship was observed between mutation frequencies and the disease incidences in the studied populations. At the individual level, no significant deficit of double-dose mutation carriers among healthy controls was found, providing strong evidence that the penetrances of the most at-risk genotypes are low. CONCLUSION: Altogether, these data confirm that CARD15/NOD2 acts in interaction with other unknown risk cofactors.
BACKGROUND:Crohn's disease (CD) has been associated with CARD15/NOD2 mutations in Caucasians. The R702W, G908R, and 1007fs mutations represent 82% of the mutated chromosomes. The relative risk of developing CD in homozygous or compound heterozygous people has been estimated as between 10 and 40 times that of the general population. This high risk may support the opinion that CARD15/NOD2 variants are strong CD risk factors at the individual and population levels. SUBJECTS AND METHODS: The allele and genotype frequencies were calculated for the R702W, G908R, and 1007fs mutations in 3,575 Caucasian healthy controls recruited by 15 groups distributed on three continents. Geographic homogeneity was tested and the observed proportion of double mutants was compared with the expected value using chi2 tests. RESULTS: The allele frequencies of the R702W, G908R, and 1007fs mutations were 4.3% (3.6-4.9), 1.2% (0.8-1.6), and 2.3% (1.8-2.8), respectively, with large geographic fluctuations of the G908R, 1007fs, and wild-type alleles (P<0.0001). At the population level, no simple relationship was observed between mutation frequencies and the disease incidences in the studied populations. At the individual level, no significant deficit of double-dose mutation carriers among healthy controls was found, providing strong evidence that the penetrances of the most at-risk genotypes are low. CONCLUSION: Altogether, these data confirm that CARD15/NOD2 acts in interaction with other unknown risk cofactors.
Authors: K Packwood; E Drewe; E Staples; D Webster; T Witte; J Litzman; W Egner; R Sargur; W Sewell; E Lopez-Granados; S L Seneviratne; R J Powell; B L Ferry; H M Chapel Journal: Clin Exp Immunol Date: 2010-09 Impact factor: 4.330
Authors: J Dhaliwal; T D Walters; D R Mack; H Q Huynh; K Jacobson; A R Otley; J Debruyn; W El-Matary; C Deslandres; M E Sherlock; J N Critch; K Bax; E Seidman; P Jantchou; A Ricciuto; M Rashid; A M Muise; E Wine; M Carroll; S Lawrence; J Van Limbergen; E I Benchimol; P Church; A M Griffiths Journal: J Crohns Colitis Date: 2020-05-21 Impact factor: 9.071
Authors: Yume Nguyen; Abed Al-Lehibi; Elizabeth Gorbe; Ellen Li; Michael Haagenson; Tao Wang; Stephen Spellman; Stephanie J Lee; Nicholas O Davidson Journal: Blood Date: 2010-02-22 Impact factor: 22.113
Authors: Lilian O Moreira; Karim C El Kasmi; Amber M Smith; David Finkelstein; Sophie Fillon; Yun-Gi Kim; Gabriel Núñez; Elaine Tuomanen; Peter J Murray Journal: Cell Microbiol Date: 2008-06-28 Impact factor: 3.715
Authors: H W Xiao; Y Luo; X Y Lai; J M Shi; Y M Tan; J S He; W Z Xie; W Y Zheng; X J Ye; X H Yu; Z Cai; M F Lin; H Huang Journal: Bone Marrow Transplant Date: 2013-10-14 Impact factor: 5.483
Authors: Mamatha Bhat; Geoffrey C Nguyen; Pierre Pare; Raymond Lahaie; Colette Deslandres; Edmond-Jean Bernard; Guy Aumais; Gilles Jobin; Gary Wild; Albert Cohen; Diane Langelier; Steven Brant; Themistocles Dassopoulos; Dermot McGovern; Esther Torres; Richard Duerr; Miguel Regueiro; Mark S Silverberg; Hillary Steinhart; Anne M Griffiths; Abdul Elkadri; Judy Cho; Deborah Proctor; Philippe Goyette; John Rioux; Alain Bitton Journal: Am J Gastroenterol Date: 2009-06-09 Impact factor: 10.864
Authors: Andrew M Smith; Farooq Z Rahman; Bu'Hussain Hayee; Simon J Graham; Daniel J B Marks; Gavin W Sewell; Christine D Palmer; Jonathan Wilde; Brian M J Foxwell; Israel S Gloger; Trevor Sweeting; Mark Marsh; Ann P Walker; Stuart L Bloom; Anthony W Segal Journal: J Exp Med Date: 2009-08-03 Impact factor: 14.307